Skip to main content

Published locations for Panel Backs Approval of Atrial Fibrillation Drug : Dronedarone reduced cardiac hospitalizations, but not mortality, in a multinational trial.

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Panel Backs Approval of Atrial Fibrillation Drug : Dronedarone reduced cardiac hospitalizations, but not mortality, in a multinational trial.

User login

  • Reset your password
  • /content/panel-backs-approval-atrial-fibrillation-drug-dronedarone-reduced-cardiac-hospitalizations
  • /familypracticenews/article/29383/cardiology/panel-backs-approval-atrial-fibrillation-drug
  • /familymedicine/article/29383/cardiology/panel-backs-approval-atrial-fibrillation-drug-dronedarone